{Reference Type}: Journal Article
{Title}: Tumors of the brachial plexus region: A 15-year experience with emphasis on motor and pain outcomes and literature review.
{Author}: Pisapia JM;Adeclat G;Roberts S;Li YR;Ali Z;Heuer GG;Zager EL;
{Journal}: Surg Neurol Int
{Volume}: 14
{Issue}: 0
{Year}: 2023
暂无{DOI}: 10.25259/SNI_163_2023
{Abstract}: <B>UNASSIGNED: </B>Brachial plexus region tumors are rare. In this study, we reviewed our experience with resection of tumors involving or adjacent to the brachial plexus to identify patterns in presentation and outcome.<BR><B>UNASSIGNED: </B>We report a retrospective case series of brachial plexus tumors operated on by a single surgeon at a single institution over 15 years. Outcome data were recorded from the most recent follow-up office visit. Findings were compared to a prior internal series and comparable series in the literature.<BR><B>UNASSIGNED: </B>From 2001 to 2016, 103 consecutive brachial plexus tumors in 98 patients met inclusion criteria. Ninety percent of patients presented with a palpable mass, and 81% had deficits in sensation, motor function, or both. Mean follow-up time was 10 months. Serious complications were infrequent. For patients with a preoperative motor deficit, the rate of postoperative motor decline was 10%. For patients without a preoperative motor deficit, the rate of postoperative motor decline was 35%, which decreased to 27% at 6 months. There were no differences in motor outcome based on extent of resection, tumor pathology, or age.<BR><B>UNASSIGNED: </B>We present one of the largest recent series of tumors of the brachial plexus region. Although the rate of worsened postoperative motor function was higher in those without preoperative weakness, the motor deficit improves over time and is no worse than antigravity strength in the majority of cases. Our findings help guide patient counseling in regard to postoperative motor function.